text: Compared to a previous smaller study of @GENE$ receptor blockade in @DISEASE$, we could not confirm that CYP11B2 -344T/C genotypes contribute towards explaining the observed variability in response to treatment with angiotensin II receptor blockers, which could be due to lack of power.